Open AccessNovel Albumin Gel-platelet-rich fibrin mixture (Alb-PRF); where do we stand?
Author(s) -
Vinayaka Ambujakshi Manjunatha,
Trinath Kishore Damera,
Akshay Kumar T K,
Rupinder Jyot Singh,
Tanmay Popat,
Devanshi Vala
Publication year - 2022
Publication title -
international journal of clinical biochemistry and research
Language(s) - English
Resource type - Journals
eISSN - 2394-6377
pISSN - 2394-6369
DOI - 10.18231/j.ijcbr.2021.051
Subject(s) - fibrin , platelet rich fibrin , biomaterial , centrifugation , platelet , albumin , biomedical engineering , platelet rich plasma , materials science , platelet concentrate , in vitro , blood product , blood proteins , fibrinogen , biology , immunology , biochemistry , pathology , medicine
AlbPRF is a blood by-product, without additives, using only autologous blood, which after centrifugation will be produced in two stages: heating and incorporation: heating of the serum and low platelet plasma and incorporation of cells (GF and PRF cytokines liquid, removed from the junction of the leukocyte zone and the red blood cells). This new biomaterial has already been tested in vitro and translational research with this new material has already started. Excellent results can be expected from the use of AlbPRF, not only for oral/periodontal surgery applications but also for use in facial medicine and aesthetics.